News
Recent shifts within the U.S. FDA reflect an increasingly complex tension between scientific rigor and accelerating political ...
Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...
MyChesCo on MSN3h
FDA Investigates Clinical Trials Sending U.S. DNA OverseasThe U.S. Food and Drug Administration (FDA) has initiated an immediate review of clinical trials involving the international ...
And more health news stories you need to start your week.
But current and former agency staff, as well as medical ethics experts, say recent cuts at the FDA are already making it more ...
Operator: Good day, everyone, and thank you for standing by. Welcome to the Vistagen Therapeutics Fiscal Year-End 2025 ...
As the market for AI enabled medical devices grows, experts say there is less transparency around device approvals.
The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...
Investor's Business Daily on MSN3d
The FDA Shake-Up Continues, And Could Impact Genetic MedicinesThe latest shake-up at the FDA forced out the top two officials in charge of reviewing cell and gene therapies, analysts said.
Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...
Pharmaceutical Technology on MSN3d
FDA cell and gene therapy director exit increases ‘volatility’ for sectorNicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...
The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ genetic data to international labs. Based on “mounting evidence,” the FDA said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback